Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.5 USD | +1.60% | -0.91% | +9.08% |
Mar. 21 | Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing | MT |
Mar. 12 | Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.08% | 7.43B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.28% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Vaxcyte, Inc. - Nasdaq
- News Vaxcyte, Inc.
- Transcript : Vaxcyte, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 02